Stockreport
Jim Cramer on Vertex Pharmaceuticals: “I Wish I Had Bought It for the Charitable Trust a Long Time Ago” [Yahoo! Finance]
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
I think Vertex is very strong. I wish I had bought it for the Charitable Trust a long time ago, when we had the CEO on. It was an excellent call, and then I got cold feet. That was a mistake. It's a good buy. Stock market data. Photo by Burak The Weekender on Pexels Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) develops and commercializes transformative medicines for serious conditions, including cystic fibrosis, sickle cell disease, and acute pain. Hardman Johnston Global Equity Strategy stated the following regarding Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) in its fourth quarter 2025 investor letter During the quarter we liquidated Corteva Inc., T-Mobile US, Inc. and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). After meetings with FDA, Vertex Pharmaceuticals Inc. does not see a path forward for a broad neuropathic chronic pain label for Journavx. This lowered potential TAM of Journavx in chronic pain. VX-993 (next generation NaV 1.8) phase II data failed to
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | VRTX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
VRTX alerts
VRTX alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
VRTX alerts
High impacting Vertex Pharmaceuticals Incorporated news events
Weekly update
A roundup of the hottest topics
VRTX
NEWS
NEWS
- Is Halozyme Therapeutics (HALO) One of the Most Undervalued Biotech Stocks to Buy Right Now? [Yahoo! Finance][Yahoo! Finance]
- 2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term [Globe and Mail, The (Toronto, Canada)][Globe and Mail, The]
- 2 Under-the-Radar Biotech Stocks Worth Buying for the Long Term [Yahoo! Finance][Yahoo! Finance]
- How an unsolved medical mystery became a life-saving breakthrough [USA TODAY][USA TODAY]
- Is Vertex Pharmaceuticals' Empire in Trouble? [Globe and Mail, The (Toronto, Canada)][Globe and Mail, The]
- More
VRTX
SEC Filings
SEC Filings
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- 4/17/26 - Form 4
- VRTX's page on the SEC website
- More